A senior pharma executive did some plain speaking at a recent summit on digitization emphasizing the need to focus less on innovation that looks "shiny" but only "lifts a very small fraction" of the organization. Rather, more widely, a blend of new and classical capabilities and driving an execution focus are critical to scale transformation initiatives.
Boehringer Ingelheim’s Formula For Scaling Transformation, Digitization
Boehringer Ingelheim’s corporate senior vice president, head of global regions, Timmo Rousku Andersen, outlines at a recent summit the company’s reshaped approach to digital innovation and the need to entrench an execution bias to scale transformation initiatives.
